Severe eosinophilic is effectively treated with benralizumab, with especially good outcomes in patients with high BEC and high FeNO.

Ravijyot Saggu explores key updates and implications of the new joint chronic asthma guidelines for diagnosis and monitoring.

Poorly controlled asthma is a predisposing factor for an acute exacerbation evoked by the aforementioned trigger factors. [40–43] Indeed, the loss of immunological balance and the rapid ...

Cole Schmidtknecht, 22, couldn't pay for his daily inhaler due to the “prohibitively expensive” price increase. Two weeks ...

A PREGNANT NHS worker who tragically died from a severe asthma attack was not given an exhale test before her death, an ...

Pre-treatment disease trajectories in severe asthma impact treatment-related outcomes, according to a study by Johannes ...

Researchers have identified immune response-related hub genes that could act as diagnostic markers and potentially ...

Chronic obstructive pulmonary disease (COPD) is a manifestation of structural violence, the process through which societies ...

The study reveals SGLT-2is are linked to fewer COPD exacerbations in type 2 diabetes, suggesting a need for further clinical ...

Researchers have found in a new study that patients with severe asthma beginning inhaled corticosteroid therapy (ICS) after ...